Ah Equity Partners Bio Ii, L.l.c. - Net Worth and Insider Trading

Ah Equity Partners Bio Ii, L.l.c. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ah Equity Partners Bio Ii, L.l.c. owns 2 companies in total, including Nautilus Biotechnology Inc (NAUT) , and EQRx Inc (EQRX) .

Click here to see the complete history of Ah Equity Partners Bio Ii, L.l.c.’s form 4 insider trades.

Insider Ownership Summary of Ah Equity Partners Bio Ii, L.l.c.

Ticker	Comapny	Transaction Date	Type of Owner
NAUT	Nautilus Biotechnology Inc	2021-06-09	10 percent owner
EQRX	EQRx Inc	2021-12-17	10 percent owner

Ah Equity Partners Bio Ii, L.l.c. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Ah Equity Partners Bio Ii, L.l.c. Ownership Network

Ownership Network List of Ah Equity Partners Bio Ii, L.l.c.

No Data

Ownership Network Relation of Ah Equity Partners Bio Ii, L.l.c.

Ah Equity Partners Bio Ii, L.l.c. Owned Company Details

What does Nautilus Biotechnology Inc do?

Who are the key executives at Nautilus Biotechnology Inc?

Ah Equity Partners Bio Ii, L.l.c. is the 10 percent owner of Nautilus Biotechnology Inc. Other key executives at Nautilus Biotechnology Inc include director & 10 percent owner & CEO & President & and Secretary Sujal M Patel , Senior VP & Product Development Subramanian Sankar , and Chief People Officer Gwen E Weld .

Nautilus Biotechnology Inc (NAUT) Insider Trades Summary

Over the past 18 months, Ah Equity Partners Bio Ii, L.l.c. made no insider transaction in Nautilus Biotechnology Inc (NAUT). Other recent insider transactions involving Nautilus Biotechnology Inc (NAUT) include a net purchase of 50,000 shares made by Sujal M Patel ,

In summary, during the past 3 months, insiders sold 0 shares of Nautilus Biotechnology Inc (NAUT) in total and bought 50,000 shares, with a net purchase of 50,000 shares. During the past 18 months, 0 shares of Nautilus Biotechnology Inc (NAUT) were sold and 50,000 shares were bought by its insiders, resulting in a net purchase of 50,000 shares.

Nautilus Biotechnology Inc (NAUT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nautilus Biotechnology Inc Insider Transactions

No Available Data

Ah Equity Partners Bio Ii, L.l.c. Mailing Address

Above is the net worth, insider trading, and ownership report for Ah Equity Partners Bio Ii, L.l.c.. You might contact Ah Equity Partners Bio Ii, L.l.c. via mailing address: 2865 Sand Hill Road, Suite 101, Menlo Park Ca 94025.

Discussions on Ah Equity Partners Bio Ii, L.l.c.

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.